Back
Mirati Therapeutics Quote, Financials, Valuation and Earnings

New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register Here
Buy
53
MRTX
Mirati Therapeutics
Last Price:
52.56
Seasonality Move:
-5.31%
7 Day Trial
ALL ACCESS PASS
$
7

Global Leader In Plant Cell Biology Poised For Rapid Growth!
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!Mirati Therapeutics Price Quote
$52.56
-0.01 (-3.13%)
(Updated: February 4, 2023 at 4:25 AM ET)
Mirati Therapeutics Key Stats
Buy
53
Mirati Therapeutics (MRTX)
is a Buy
Day range:
$51.62 - $53.55
52-week range:
$32.96 - $124.81
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
245.96
P/B ratio:
2.68%
Volume:
1M
Avg. volume:
1.4M
1-year change:
-55.39%
Market cap:
$3B
Revenue:
$72.1M
EPS:
$-13.39
How Much Does Mirati Therapeutics Make?
-
How Much Are Mirati Therapeutics's Sales Annually?
MRTX Revenues are $72.1M -
How Much Profit Does Mirati Therapeutics's Make A Year?
MRTX net income is -$582.5M
Is Mirati Therapeutics Growing As A Company?
-
What Is Mirati Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.92% -
What Is Mirati Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Mirati Therapeutics Stock Price Performance
-
Did Mirati Therapeutics Stock Go Up Last Month?
Mirati Therapeutics share price went up by 12.69% last month -
Did MRTX's Share Price Rise Over The Last Year?
MRTX share price fell by -55.39% over the past 1 year
What Is Mirati Therapeutics 52-Week High & Low?
-
What Is Mirati Therapeutics’s 52-Week High Share Price?
Mirati Therapeutics has traded as high as $124.81 over the past 52 weeks -
What Is Mirati Therapeutics’s 52-Week Low Share Price?
Mirati Therapeutics has traded as low as $32.96 over the past 52 weeks
Mirati Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mirati Therapeutics?
-
How Much Debt Does Mirati Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Mirati Therapeutics Have?
Cash and short term investments quarterly total is $1.2B -
What Is Mirati Therapeutics’s Book Value Per Share?
Book value per share is 19.61
Is Mirati Therapeutics Cash Flow Positive?
-
What Is MRTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$579.8M -
What Is Mirati Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $640.3M -
What Is Mirati Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.3M
Mirati Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
MRTX return on invested capital is -61.93% -
What Is Mirati Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -54.02% -
What Is MRTX Return On Equity?
ROE is a measure of profitability and is -61.93%
Mirati Therapeutics Earnings Date & Stock Price
-
What Is Mirati Therapeutics's Stock Price Today?
A single share of MRTX can be purchased today for 52.57 -
What Is Mirati Therapeutics’s Stock Symbol?
Mirati Therapeutics trades on the nasdaq under the ticker symbol: MRTX -
When Is Mirati Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Mirati Therapeutics is scheduled on February 28, 2023 -
When Is MRTX's next ex-dividend date?
Mirati Therapeutics's next ex-dividend date is February 6, 2023 -
How To Buy Mirati Therapeutics Stock?
You can buy Mirati Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mirati Therapeutics Competitors
-
Who Are Mirati Therapeutics's Competitors?
Below is a list of companies who compete with Mirati Therapeutics or are related in some way:
Mirati Therapeutics Dividend Yield
Data Unavailable
Mirati Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 11.33% |
Revenue: | -92.44% | 295.32% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 8 |
Sell Recommendations: | 0 |
Price Target: | 71.27 |
Upside from Last Price: | 35.57% |